Sangamo reports disappointing results from earlystage studies of zinc finger nuclease gene editing httpswww.firstwordpharma.comnode1623928Â $SGMO WORLDSymposia

Sangamo reports disappointing results from early-stage studies of zinc finger nuclease gene editing https://www.firstwordpharma.com/node/1623928  $SGMO #WORLDSymposia

11:55 EST 7 Feb 2019 | FirstWord Pharma

Sangamo reports disappointing results from early-stage studies of zinc finger nuclease gene editing https://www.firstwordpharma.com/node/1623928  $SGMO #WORLDSymposia

More From BioPortfolio on "Sangamo reports disappointing results from early-stage studies of zinc finger nuclease gene editing https://www.firstwordpharma.com/node/1623928  $SGMO #WORLDSymposia"